These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 21382300

  • 41. Social competence and positive and negative symptoms: a longitudinal study of children and adolescents at risk for schizophrenia and affective disorder.
    Dworkin RH, Bernstein G, Kaplansky LM, Lipsitz JD, Rinaldi A, Slater SL, Cornblatt BA, Erlenmeyer-Kimling L.
    Am J Psychiatry; 1991 Sep; 148(9):1182-8. PubMed ID: 1882996
    [Abstract] [Full Text] [Related]

  • 42. Social competence in schizoaffective disorder, bipolar disorder, and negative and non-negative schizophrenia.
    Bellack AS, Morrison RL, Mueser KT, Wade J.
    Schizophr Res; 1989 Sep; 2(4-5):391-401. PubMed ID: 2487180
    [Abstract] [Full Text] [Related]

  • 43. DTNBP1 genotype influences cognitive decline in schizophrenia.
    Burdick KE, Goldberg TE, Funke B, Bates JA, Lencz T, Kucherlapati R, Malhotra AK.
    Schizophr Res; 2007 Jan; 89(1-3):169-72. PubMed ID: 17074466
    [Abstract] [Full Text] [Related]

  • 44. A prognostic study of clinical dimensions in adolescent-onset psychoses.
    Paillère-Martinot ML, Aubin F, Martinot JL, Colin B.
    Schizophr Bull; 2000 Jan; 26(4):789-99. PubMed ID: 11087012
    [Abstract] [Full Text] [Related]

  • 45. Vulnerability and schizoaffective psychosis: a two-factor model.
    Braden W.
    Schizophr Bull; 1984 Jan; 10(1):71-86. PubMed ID: 6701480
    [Abstract] [Full Text] [Related]

  • 46. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.
    Dickerson F, Schroeder J, Stallings C, Origoni A, Katsafanas E, Schwienfurth LA, Savage CL, Khushalani S, Yolken R.
    Schizophr Res; 2014 Jul; 156(2-3):248-53. PubMed ID: 24827555
    [Abstract] [Full Text] [Related]

  • 47. Cognitive intermediate phenotype and genetic risk for psychosis.
    Mark W, Toulopoulou T.
    Curr Opin Neurobiol; 2016 Feb; 36():23-30. PubMed ID: 26363129
    [Abstract] [Full Text] [Related]

  • 48. Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?
    Nelson B, Sass LA, Thompson A, Yung AR, Francey SM, Amminger GP, McGorry PD.
    Early Interv Psychiatry; 2009 May; 3(2):83-93. PubMed ID: 21352181
    [Abstract] [Full Text] [Related]

  • 49. Frequency and phenomenology of persisting alterations in affective, schizoaffective and schizophrenic disorders: a comparison.
    Marneros A, Rohde A, Deister A.
    Psychopathology; 1998 May; 31(1):23-8. PubMed ID: 9500683
    [Abstract] [Full Text] [Related]

  • 50. The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.
    Nakagami E, Hoe M, Brekke JS.
    Schizophr Bull; 2010 Sep; 36(5):935-48. PubMed ID: 20462998
    [Abstract] [Full Text] [Related]

  • 51. Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.
    Spellmann I, Riedel M, Städtler J, Zill P, Obermeier M, Cerovecki A, Dehning S, Schennach R, Epple M, Opgen-Rhein M, Müller N, Bondy B, Möller HJ, Musil R.
    Cogn Neuropsychiatry; 2017 Jul; 22(4):280-297. PubMed ID: 28470106
    [Abstract] [Full Text] [Related]

  • 52. Processing speed differences between schizophrenia and schizoaffective disorder: A pilot study.
    Mondragón-Maya A, Flores-Medina Y, Ramos-Mastache D, Vales MR, Olivares Neumann JL, Escamilla-Orozco R, Saracco-Álvarez R.
    Psychiatr Danub; 2019 Sep; 31(3):355-357. PubMed ID: 31596829
    [Abstract] [Full Text] [Related]

  • 53. EEG-power spectral components of schizoaffective disorders.
    Schellenberg R, Knorr W, Schindler M, Kropf S, Beyer H.
    Schizophr Res; 1990 Sep; 3(5-6):357-9. PubMed ID: 2282342
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Comparison of cognitive performance in RDC-diagnosed schizoaffective and schizophrenic patients with the Luria-Nebraska Neuropsychological Battery.
    Miller LS, Swanson-Green T, Moses JA, Faustman WO.
    J Psychiatr Res; 1996 Sep; 30(4):277-82. PubMed ID: 8905536
    [Abstract] [Full Text] [Related]

  • 56. Morbidity risks of schizophrenia and affective disorders among first-degree relatives of patients with schizoaffective disorders.
    Tsuang MT.
    Br J Psychiatry; 1991 Feb; 158():165-70. PubMed ID: 2012906
    [Abstract] [Full Text] [Related]

  • 57. Trajectories of social withdrawal and cognitive decline in the schizophrenia prodrome.
    Cullen K, Guimaraes A, Wozniak J, Anjum A, Schulz SC, White T.
    Clin Schizophr Relat Psychoses; 2011 Jan; 4(4):229-38. PubMed ID: 21177240
    [Abstract] [Full Text] [Related]

  • 58. Association between psychopathology and problems of psychosocial functioning in the long-term outcome of patients diagnosed with schizophrenic, schizoaffective and affective disorders.
    Bottlender R, Strauss A, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2013 Mar; 263(2):85-92. PubMed ID: 22722960
    [Abstract] [Full Text] [Related]

  • 59. Acute and transient psychotic disorder: a 1-year follow-up study.
    Jørgensen P, Bennedsen B, Christensen J, Hyllested A.
    Acta Psychiatr Scand; 1997 Aug; 96(2):150-4. PubMed ID: 9272200
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.